journal article·2021-11-10Open access

Therapeutic Delivery of Nitric Oxide Utilizing Saccharide-Based Materials

Yun Qian, Rajnish Kumar, Manjyot Kaur Chug, Hamed Massoumi, Elizabeth J. Brisbois

ACS Applied Materials & Interfaces· Volume 13· Issue 44

Abstract

As a gasotransmitter, nitric oxide (NO) regulates physiological pathways and demonstrates therapeutic effects such as vascular relaxation, anti-inflammation, antiplatelet, antithrombosis, antibacterial, and antiviral properties. However, gaseous NO has high reactivity and a short half-life, so NO delivery and storage are critical questions to be solved. One way is to develop stable NO donors and the other way is to enhance the delivery and storage of NO donors from biomaterials. Most of the researchers studying NO delivery and applications are using synthetic polymeric materials, and they have demonstrated significant therapeutic effects of these NO-releasing polymeric materials on cardiovascular diseases, respiratory disease, bacterial infections, etc. However, some researchers are exploring saccharide-based materials to fulfill the same tasks as their synthetic counterparts while avoiding the concerns of biocompatibility, biodegradability, and sustainability. Saccharide-based materials are abundant in nature and are biocompatible and biodegradable, with wide applications in bioengineering, drug delivery, and therapeutic disease treatments. Saccharide-based materials have been implemented with various NO donors (like S-nitrosothiols and N-diazeniumdiolates) via both chemical and physical methods to deliver NO. These NO-releasing saccharide-based materials have exhibited controlled and sustained NO release and demonstrated biomedical applications in various diseases (respiratory, Crohn’s, cardiovascular, etc.), skin or wound applications, antimicrobial treatment, bone regeneration, anticoagulation, as well as agricultural and food packaging. This review aims to highlight the studies in methods and progress in developing saccharide-based NO-releasing materials and investigating their potential applications in biomedical, bioengineering, and disease treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nitric Oxide and Endothelin Effects · Nanoplatforms for cancer theranostics · Advanced Sensor and Energy Harvesting Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemical, Materials & Biomedical Engineering, University of Georgia, Athens, Georgia 30602, United States

Funding

National Heart, Lung, and Blood Institute · JDRF

References (100+)

Show source-provided references
1. 10.1038/sj.bjp.070645810.1038/sj.bjp.0706458 ↗
2. 10.1038/ni1001-90710.1038/ni1001-907 ↗
3. 10.1016/j.addr.2016.06.01710.1016/j.addr.2016.06.017 ↗
4. 10.1097/MCO.0b013e328332f99d10.1097/MCO.0b013e328332f99d ↗
5. 10.1046/j.1472-8206.2003.00124.x10.1046/j.1472-8206.2003.00124.x ↗
6. 10.1089/15230860130018517910.1089/152308601300185179 ↗
7. 10.1016/j.drup.2006.05.00310.1016/j.drup.2006.05.003 ↗
8. 10.1007/s10787-007-0013-x10.1007/s10787-007-0013-x ↗
9. 10.1039/c2cs15273h10.1039/c2cs15273h ↗
10. 10.1016/S1567-5769(01)00086-810.1016/S1567-5769(01)00086-8 ↗
11. 10.1038/nrcardio.2017.22410.1038/nrcardio.2017.224 ↗
12. 10.1002/med.2009210.1002/med.20092 ↗
13. 10.1016/j.jcf.2013.01.00810.1016/j.jcf.2013.01.008 ↗
14. 10.1016/j.ijpharm.2014.06.05110.1016/j.ijpharm.2014.06.051 ↗
15. 10.1172/JCI11947310.1172/JCI119473 ↗
16. 10.1093/bja/71.5.70210.1093/bja/71.5.702 ↗
17. 10.1016/j.freeradbiomed.2008.03.02010.1016/j.freeradbiomed.2008.03.020 ↗
18. 10.1021/acs.jmedchem.6b0167210.1021/acs.jmedchem.6b01672 ↗
19. 10.1016/j.addr.2018.04.01010.1016/j.addr.2018.04.010 ↗
20. 10.4155/tde-2017-003710.4155/tde-2017-0037 ↗
21. 10.1056/NEJM19970227336090210.1056/NEJM199702273360902 ↗
22. 10.1002/14651858.CD002787.pub310.1002/14651858.CD002787.pub3 ↗
23. 10.1213/ANE.0b013e31820bd18510.1213/ANE.0b013e31820bd185 ↗
24. 10.1016/j.cardiores.2007.04.01410.1016/j.cardiores.2007.04.014 ↗
25. Muzykantov V. · Int. J. Transp. Phenom. · 2011 · 12 · 41
26. 10.1016/j.addr.2020.06.01310.1016/j.addr.2020.06.013 ↗
27. 10.1016/j.tibs.2014.03.00310.1016/j.tibs.2014.03.003 ↗
28. 10.1161/01.CIR.74.2.22210.1161/01.CIR.74.2.222 ↗
29. 10.1016/j.vph.2014.09.00210.1016/j.vph.2014.09.002 ↗
30. 10.1021/cr000040l10.1021/cr000040l ↗
31. 10.1161/HYPERTENSIONAHA.117.0973710.1161/HYPERTENSIONAHA.117.09737 ↗
32. 10.1021/acs.molpharmaceut.7b0100310.1021/acs.molpharmaceut.7b01003 ↗
33. 10.3171/jns.2003.99.2.035110.3171/jns.2003.99.2.0351 ↗
34. 10.1039/C7CC06574D10.1039/C7CC06574D ↗
35. 10.3389/fphar.2020.0092310.3389/fphar.2020.00923 ↗
36. 10.1002/adhm.20200155010.1002/adhm.202001550 ↗
37. 10.1039/C8TB00299A10.1039/C8TB00299A ↗
38. 10.1021/acsabm.9b0090810.1021/acsabm.9b00908 ↗
39. 10.1021/acsami.1c0642710.1021/acsami.1c06427 ↗
40. 10.1021/acsabm.9b0059310.1021/acsabm.9b00593 ↗
41. 10.1016/j.actbio.2014.06.03210.1016/j.actbio.2014.06.032 ↗
42. 10.1016/j.biomaterials.2013.05.06310.1016/j.biomaterials.2013.05.063 ↗
43. 10.7860/JCDR/2015/13907.656510.7860/JCDR/2015/13907.6565 ↗
44. Prestegard J. H. · 2017
45. 10.1002/pat.326610.1002/pat.3266 ↗
46. 10.1016/j.jconrel.2018.06.02610.1016/j.jconrel.2018.06.026 ↗
47. 10.1016/j.ijpharm.2004.10.02210.1016/j.ijpharm.2004.10.022 ↗
48. 10.1016/j.ijpharm.2014.06.05510.1016/j.ijpharm.2014.06.055 ↗
49. 10.1016/j.carbpol.2016.07.06910.1016/j.carbpol.2016.07.069 ↗
50. 10.15376/biores.1.2.270-28010.15376/biores.1.2.270-280 ↗
51. 10.1016/j.carbpol.2019.11558510.1016/j.carbpol.2019.115585 ↗
52. 10.3390/md1308515610.3390/md13085156 ↗
53. 10.1016/j.engreg.2020.10.00110.1016/j.engreg.2020.10.001 ↗
54. 10.1016/j.progpolymsci.2011.06.00310.1016/j.progpolymsci.2011.06.003 ↗
55. 10.1161/01.CIR.49.4.60310.1161/01.CIR.49.4.603 ↗
56. McGann, C.; Kiick, K. Heparin-Functionalized Materials in Tissue Engineering Applications. Springer New York: 2012; pp 225–250.10.1007/978-1-4614-1080-5_9 ↗
57. Stephen A. M. · 2006 · 7
58. 10.2217/nnm.12.14910.2217/nnm.12.149 ↗
59. 10.1002/star.20190027010.1002/star.201900270 ↗
60. 10.1016/0960-894X(96)00484-210.1016/0960-894X(96)00484-2 ↗
61. Hou Y. · 1999 · 24210.1016/S0076-6879(99)01088-5 ↗
62. 10.1016/S0040-4039(00)02158-410.1016/S0040-4039(00)02158-4 ↗
63. 10.1016/S0968-0896(02)00064-010.1016/S0968-0896(02)00064-0 ↗
64. 10.1002/(SICI)1097-0142(20000115)88:2<381::AID-CNCR20>3.0.CO;2-M10.1002/(SICI)1097-0142(20000115)88:2<381::AID-CNCR20>3.0.CO;2-M ↗
65. 10.1016/S0040-4039(01)00614-110.1016/S0040-4039(01)00614-1 ↗
66. 10.1016/j.ijbiomac.2015.04.07310.1016/j.ijbiomac.2015.04.073 ↗
67. 10.3390/polym1004045210.3390/polym10040452 ↗
68. 10.1016/j.nano.2016.05.00610.1016/j.nano.2016.05.006 ↗
69. 10.1016/j.ijpharm.2015.08.07410.1016/j.ijpharm.2015.08.074 ↗
70. 10.1021/acs.jafc.6b0193610.1021/acs.jafc.6b01936 ↗
71. 10.1186/s13568-015-0114-710.1186/s13568-015-0114-7 ↗
72. 10.1039/C4TB00996G10.1039/C4TB00996G ↗
73. 10.1021/jp025756u10.1021/jp025756u ↗
74. 10.2174/157341371130901000310.2174/1573413711309010003 ↗
75. 10.1016/j.foodchem.2019.01.15610.1016/j.foodchem.2019.01.156 ↗
76. 10.1039/C6MD00502K10.1039/C6MD00502K ↗
77. 10.1088/1742-6596/304/1/01204510.1088/1742-6596/304/1/012045 ↗
78. 10.1016/j.niox.2016.09.01010.1016/j.niox.2016.09.010 ↗
79. 10.1016/j.carbpol.2005.09.02310.1016/j.carbpol.2005.09.023 ↗
80. 10.1039/C4TB01340A10.1039/C4TB01340A ↗
81. 10.1517/17425247.2015.102891610.1517/17425247.2015.1028916 ↗
82. 10.1128/AAC.01208-1510.1128/AAC.01208-15 ↗
83. 10.1016/j.actbio.2014.10.02810.1016/j.actbio.2014.10.028 ↗
84. 10.1080/08927014.2015.110754810.1080/08927014.2015.1107548 ↗
85. 10.1002/app.3113010.1002/app.31130 ↗
86. 10.1016/j.biomaterials.2013.11.01510.1016/j.biomaterials.2013.11.015 ↗
87. 10.1021/acsbiomaterials.7b0003910.1021/acsbiomaterials.7b00039 ↗
88. 10.1016/j.ijbiomac.2008.07.01610.1016/j.ijbiomac.2008.07.016 ↗
89. 10.1016/j.biomaterials.2013.07.04510.1016/j.biomaterials.2013.07.045 ↗
90. 10.1016/j.actbio.2017.08.03710.1016/j.actbio.2017.08.037 ↗
91. 10.3109/10717544.2015.112267610.3109/10717544.2015.1122676 ↗
92. 10.1021/acs.biomac.8b0006310.1021/acs.biomac.8b00063 ↗
93. 10.1021/acsbiomaterials.9b0048210.1021/acsbiomaterials.9b00482 ↗
94. 10.1021/acsami.8b0684810.1021/acsami.8b06848 ↗
95. 10.1039/c2jm34834a10.1039/c2jm34834a ↗
96. 10.1021/cr500081p10.1021/cr500081p ↗
97. 10.1021/cr970022c10.1021/cr970022c ↗
98. 10.1039/B816354P10.1039/B816354P ↗
99. 10.1039/c0cs00153h10.1039/c0cs00153h ↗
100. 10.1023/A:101582441756910.1023/A:1015824417569 ↗